Vaccines

Data from the CDC on the Delta variant and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

In a new analysis of adults without immunocompromising conditions, vaccine effectiveness against hospitalization was higher for Moderna than Pfizer and Johnson & Johnson.

Pfizer/BioNTech report "robust" antibody response to COVID-19 vaccine in children aged 5 to 11 years with safety profile comparable to that seen in persons aged 16 to 25 years.